AR and prostate cancer: Consequently, using the cutoff of 2.0 for AR gain would mean that a tumor would be considered abnormal for AR gain when AR copy number is at least doubled (from one copy in normal male cells to two copies in cancer cells) in 100% of the cells, which might be too stringent a criterion and explains why AR gain was never reported previously in primary prostate cancer.